CompaniesProlexys Pharmaceuticals

Prolexys Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

77

By Phase

PHASE1/PHASE2: 1PHASE1: 1

By Status

UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
Today
NCT00528047
NCT01695590
Hover over trial bars to see details

Recent Trials

NCT01695590Lead Sponsor
Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
PHASE1/PHASE2Unknown
40 participants
Started: Mar 31, 2012 · Completed: Sep 30, 2014
NCT00528047Lead Sponsor
Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors
PHASE1Completed
37 participants
Started: Aug 31, 2007 · Completed: Nov 30, 2011